296 related articles for article (PubMed ID: 25446919)
1. Erythropoietin protects myocardium against ischemia-reperfusion injury under moderate hyperglycemia.
Jun JH; Jun NH; Shim JK; Shin EJ; Kwak YL
Eur J Pharmacol; 2014 Dec; 745():1-9. PubMed ID: 25446919
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor GATA-4 is involved in erythropoietin-induced cardioprotection against myocardial ischemia/reperfusion injury.
Shan X; Xu X; Cao B; Wang Y; Guo L; Zhu Q; Li J; Que L; Chen Q; Ha T; Li C; Li Y
Int J Cardiol; 2009 May; 134(3):384-92. PubMed ID: 18672303
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin prevents hypoxia-induced GATA-4 ubiquitination via phosphorylation of serine 105 of GATA-4.
Jun JH; Shin EJ; Kim JH; Kim SO; Shim JK; Kwak YL
Biol Pharm Bull; 2013; 36(7):1126-33. PubMed ID: 23811561
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin-activated ERK/MAP kinase enhances GATA-4 acetylation via phosphorylation of serine 261 of GATA-4.
Jun JH; Shim JK; Ryoo HM; Kwak YL
J Cell Physiol; 2013 Jan; 228(1):190-7. PubMed ID: 22674427
[TBL] [Abstract][Full Text] [Related]
5. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
[TBL] [Abstract][Full Text] [Related]
6. Effect and mechanism of propofol on myocardial ischemia reperfusion injury in type 2 diabetic rats.
Lin C; Sui H; Gu J; Yang X; Deng L; Li W; Ding W; Li D; Yang Y
Microvasc Res; 2013 Nov; 90():162-8. PubMed ID: 23988878
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV enhances GATA-4 mediated myocardial protection effect in hypoxia/reoxygenation injured H9c2 cells.
Yang JJ; Zhang XH; Ma XH; Duan WJ; Xu NG; Chen YJ; Liang L
Nutr Metab Cardiovasc Dis; 2020 May; 30(5):829-842. PubMed ID: 32278611
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of fasudil hydrochloride post-conditioning on acute myocardial ischemia/reperfusion injury in rats.
Jiang ZH; Zhang TT; Zhang JF
Cardiol J; 2013; 20(2):197-202. PubMed ID: 23558879
[TBL] [Abstract][Full Text] [Related]
11. Luteolin Inhibits Ischemia/Reperfusion-Induced Myocardial Injury in Rats via Downregulation of microRNA-208b-3p.
Bian C; Xu T; Zhu H; Pan D; Liu Y; Luo Y; Wu P; Li D
PLoS One; 2015; 10(12):e0144877. PubMed ID: 26658785
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo.
Bullard AJ; Govewalla P; Yellon DM
Basic Res Cardiol; 2005 Sep; 100(5):397-403. PubMed ID: 15944807
[TBL] [Abstract][Full Text] [Related]
13. Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK.
Su H; Sun X; Ma H; Zhang HF; Yu QJ; Huang C; Wang XM; Luan RH; Jia GL; Wang HC; Gao F
Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E629-35. PubMed ID: 17519283
[TBL] [Abstract][Full Text] [Related]
14. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism.
Zhang KR; Liu HT; Zhang HF; Zhang QJ; Li QX; Yu QJ; Guo WY; Wang HC; Gao F
Apoptosis; 2007 Sep; 12(9):1579-88. PubMed ID: 17505785
[TBL] [Abstract][Full Text] [Related]
15. Antiapoptosis and mitochondrial effect of pioglitazone preconditioning in the ischemic/reperfused heart of rat.
Li J; Lang MJ; Mao XB; Tian L; Feng YB
Cardiovasc Drugs Ther; 2008 Aug; 22(4):283-91. PubMed ID: 18470603
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase.
Burger D; Lei M; Geoghegan-Morphet N; Lu X; Xenocostas A; Feng Q
Cardiovasc Res; 2006 Oct; 72(1):51-9. PubMed ID: 16904088
[TBL] [Abstract][Full Text] [Related]
17. Targeting MIAT reduces apoptosis of cardiomyocytes after ischemia/reperfusion injury.
Chen L; Zhang D; Yu L; Dong H
Bioengineered; 2019 Dec; 10(1):121-132. PubMed ID: 30971184
[TBL] [Abstract][Full Text] [Related]
18. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
[TBL] [Abstract][Full Text] [Related]
19. Globular adiponectin attenuates myocardial ischemia/reperfusion injury by upregulating endoplasmic reticulum Ca²⁺-ATPase activity and inhibiting endoplasmic reticulum stress.
Guo J; Bian Y; Bai R; Li H; Fu M; Xiao C
J Cardiovasc Pharmacol; 2013 Aug; 62(2):143-53. PubMed ID: 23609327
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin attenuates apoptosis after ischemia-reperfusion-induced renal injury in transiently hyperglycemic Wister rats.
Caetano AM; Vianna Filho PT; Castiglia YM; Golim MA; de Souza AV; de Carvalho LR; Deffune E; de Oliveira C; Vianna PT
Transplant Proc; 2011 Dec; 43(10):3618-21. PubMed ID: 22172815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
